Health

ReGen 2025 Conference on Regenerative Medicine Begins with Launch of India’s First Guidelines for Platelet-Rich Plasma Therapy

deccanwebtv Aug 2, 2025

Chennai, 02 August 2025: The second edition of ReGen 2025, a two-day international conference on regenerative medicine, orthobiologics, pain management, and sports injury rehabilitation, commenced today in Chennai, drawing over 500 healthcare professionals from across India and abroad. The event marked a significant milestone in India’s medical landscape with the launch of the country’s first-ever Platelet-Rich Plasma (PRP) Guidelines, a standardised, evidence-based framework for PRP therapy, a transformative blood-based treatment for orthopedic, sports-related, and degenerative conditions.

Regenerative Medicine is a field of medicine that focuses on repairing, regenerating, or replacing damaged cells, tissues, or organs using the body’s natural healing processes. PRP therapy uses a concentrated dose of a patient’s own platelets to accelerate healing of injured tissues.

The conference featured more than 60 speakers and panellists, including global stalwarts in regenerative medicine, and hosted over 25 high-impact plenary and interactive sessions on various aspects of regenerative medicine, which focuses on harnessing the body’s natural healing abilities to repair or replace damaged cells, tissues, and organs with growing promise across orthopedic, neurological, and musculoskeletal applications.

As part of the ReGen 2025 conference, a one-day hands-on workshop was conducted yesterday at the Tamil Nadu Government Multi Super Speciality Hospital in the city, offering participants direct exposure to imaging-guided regenerative treatment procedures, case-based discussions, and live demonstrations of best practices in regenerative therapy.

In her comments at the inaugural session of the conference, Dr. Sharmila Tulpule, Consultant Orthopedic Surgeon & Regenerative Medicine Specialist and Founder Director – Orthobiologix Clinic, and the Chairperson of ReGen 2025 said, “We are proud to host ReGen 2025, a landmark gathering that brings together some of the brightest minds in regenerative medicine from India and across the world. As regenerative medicine rapidly evolves into one of the most promising frontiers in healthcare, conferences like this play a vital role in accelerating research, clinical adoption, and policy alignment. ReGen 2025 proved itself as a dynamic platform for knowledge exchange, hands-on learning, and global collaboration. From keynote lectures on gene editing and tissue engineering to live workshops, research sessions, and an innovation showcase, ReGen 2025 is designed to shape the future of biologic therapies in India. The unveiling of India’s first PRP guidelines at the conference is a major milestone.”

In his comments, Dr. G. K. Kumar, Professor and Head, Department of Anesthesia & Pain Medicine, Tamil Nadu Government Multi Super Speciality Hospital, Chennai, said, “The launch of India’s first-ever PRP guidelines marks a turning point for regenerative medicine in the country. Though PRP therapy has become a cornerstone of biologic treatment worldwide, the standardised protocols were absent in India. It led to inconsistent practices and outcomes. However, these newly released guidelines fill that critical gap by providing a comprehensive, evidence-based framework. With a strong focus on patient-centered care, the guidelines also emphasise informed consent and long-term follow-up. Rigorously developed by 17 leading experts and validated through, this landmark document sets a new benchmark for clinical excellence in India’s regenerative practices with the highest global standards.”

Talking about the conference, Mr. Niteen Tulpule, Co-Founder & Director, Orthobiologix Biotech Pvt. Ltd,, said, “The topics covered included cutting-edge regenerative procedures and technologies, including autologous blood products, which are therapies derived from the patient’s own blood to stimulate healing; allogenic cell therapy, which refers to the use of donor cells to repair or regenerate tissue; growth factor therapies that are applications of bioactive proteins to promote tissue regeneration, and bone marrow aspirate concentrate, a potent source of stem cells used in musculoskeletal and cartilage repair. These technologies are rapidly reshaping clinical protocols by offering minimally invasive, personalised solutions to chronic pain, sports injuries, and degenerative diseases, reducing recovery time and improving long-term outcomes.”

In his address, Dr A Navaladishankar, Senior Consultant Orthopaedic Surgeon, Apollo Hospital Chennai, said, “The release of these PRP guidelines at ReGen 2025 is not just a scientific achievement. It’s a rallying point for India’s entire regenerative medicine ecosystem. With our vast clinical expertise and growing patient base, India is uniquely positioned to lead in the global regenerative movement. These guidelines lay the foundation for safe, standardised, and evidence-based care. We urge clinicians, researchers, and policymakers to embrace this moment as a turning point in how we approach healing and patient care.”

Kauvery Hospital Vadapalani Introduces Full-Spectrum Hypertrophic Cardiomyopathy (HCM) Clinic

deccanwebtv Jul 27, 2025

Kauvery Hospital Vadapalani Introduces Full-Spectrum Hypertrophic Cardiomyopathy (HCM) Clinic
Bringing Together All Modalities of Treatment in One Place

Chennai, 23 July 2025: Kauvery Hospital, Vadapalani, one of Chennai’s prominent health-care center has announced the launch of its Hypertrophic Cardiomyopathy (HCM) Clinic, a facility designed to offer patients a comprehensive approach to managing this complex cardiac condition. The clinic brings together a range of diagnostic and treatment options, many of which are often offered in isolation across different institutions, now accessible in one integrated setting.

Hypertrophic Cardiomyopathy is a condition where the heart muscle thickens abnormally, often due to genetic factors. This thickening can interfere with the heart’s ability to pump blood effectively, leading to symptoms such as chest pain, breathlessness, fatigue, fainting, and in some cases, sudden cardiac death, especially in younger individuals. Early diagnosis and a structured treatment approach can significantly improve long-term outcomes.

HCM Clinic will be only one of its kind to offer the whole gamut of services;
from a genuine genetic testing, (PGT-M) to genetic counselling, and family screening diagnostics in cardiogenetics, from focused diagnostics from biomarker to advanced echo, and MRI Imaging, from routine diagnostic cath to alcohol septal ablation (ASA) to the latest SESAME tech,
from continous electrical monitoring with holter to advanced electrophysiological studies with ablation and devices like pacemaker and ICDs, from septal myectomy to mitral valve repair. A rare case scenario when patient reaches a burnout phase, patient may need evaluation for heart transplantation. Kauvery Hospital, Vadapalani promises to offer all of the above under one roof within its core competence in personalized, focused, and affordable care.

Speaking about the initiative, Prof. Dr P. Manokar, senior interventional cardiologist, Clinical Lead – Heart Failure & Transplant Program at Kauvery Hospital Vadapalani, said, “HCM is not a one-size-fits-all condition. Each patient presents differently, and the management needs to be tailored accordingly. Our approach focuses on identifying the condition early, especially in families with a known history, and offering every treatment option available medical, procedural, surgical in a structured and coordinated manner.”

Dr. Anbarasu Mohanraj, Clinical Lead & Senior Consultant, Cardiovascular & Thoracic Surgery, added, “Surgical intervention such as septal myectomy or mitral valve procedures can be life-changing for patients with obstructive HCM who do not respond well to medications or other treatments. At our HCM Clinic, we assess each case through a multi-disciplinary lens, ensuring that surgical decisions are precise and aligned with the individual’s long-term prognosis.”

A Heart Team Approach which is lacking in many organizations in India, is the key focus of this HCM Clinic. The Heart Team in Kauvery, Vadapalani is a team based approach to this disease, so that the best possible therapy is offered to our patient, by the best experts in this field – all under one roof.

Dr. Aravindan  Selvaraj, Co-founder and Executive Director of Kauvery Group of Hospitals added, “This clinic brings together all the modalities of HCM care that are usually scattered across departments or even different hospitals. Our aim is to make it easier for patients and families to access every form of treatment they may need, from first consultation to advanced procedures, without unnecessary delays or referrals. We believe such an approach can improve diagnosis, reduce risk, and lead to better quality of life for patients living with this condition.”

By consolidating expertise from multiple disciplines such as cardiology, electrophysiology, genetics, psychology, and cardiac surgery, the HCM Clinic at Kauvery Hospital Vadapalani sets a new direction in how this challenging condition can be addressed especially for patients who may not otherwise receive coordinated care.

VIPOS 2025: Shaping the Future of Precision Oncology from Chennai

deccanwebtv Jul 20, 2025

Chennai, July 20, 2025: The VS International Precision Oncology Summit (VIPOS 2025), under the aegis of VS Medical Trust, held from July 18 to 20, 2025 at Hotel Green Park, Chennai, brought together over 500 delegates from across India, including medical, surgical, and radiation oncologists, physicians, pathologists, geneticists, researchers, and postgraduate students, for a powerful and collaborative exchange on the evolving landscape of cancer care.

The summit focused on the growing role of precision oncology, from advanced diagnostics and targeted therapies to patient-specific treatment strategies. Over the three days, participants engaged in insightful sessions, case discussions, panel talks, and research presentations that highlighted real-world challenges, innovations, and solutions.

A key feature of the event was the enthusiastic participation of young minds, with poster presentations by postgraduate students showcasing fresh ideas, emerging research, and field experiences that sparked meaningful discussions.

One of the emotional highlights of the summit was the Prof. Dr. S. Subramanian Oration, delivered by Dr. Ramesh B. V. Nimmagadda, who shared powerful insights on real-world data and collaborative oncology platforms. He was also honoured with the VS Hospitals Award for Excellence in Oncology, in recognition of his impactful work in cancer outcomes through data-driven efforts.

VIPOS 2025 was conceived and conducted by Dr. S. Nithya, Associate Director – Medical Oncology Services, who led the academic planning and coordination of the summit. The event was graced by Prof. Dr. S. Sundar, Medical Director, and Mr. Muthu Subramanian, Executive Director – both of whom played key roles in shaping the summit’s vision and presence.

The event was held under the guiding vision of Prof. Dr. S. Subramanian, India’s Senior Most Practising Medical Oncologist, Founder Chairman and Managing Director of VS Group of Hospitals, whose commitment to making quality cancer care accessible continues to drive the institution’s journey.

The seamless execution and overall success of the summit were made possible through the leadership and strategic oversight of Mr. Prassanna Srinivasan, Group Chief Operating Officer, whose sharp focus on excellence and collaboration brought every detail to life.

More than a scientific conference, VIPOS 2025 was a purposeful gathering, where experience met innovation, and every conversation echoed a shared mission: to make cancer care more precise, compassionate, and impactful for every patient.

Prashanth Hospitals Becomes City’s First To Successfully Heal 500 Patients withRobotic Knee Replacement Surgeries Using 4th Gen Velys Tech

deccanwebtv Jun 27, 2025

● Dr. Arumugam S, who leads the hospital’s Orthopaedic robotic knee replacement
program, becomes one of India’s top five surgeons to cross 500 surgeries using the

advanced 4 th Gen Velys.

Chennai, 26 th June, 2025: In a major advancement for precision-led orthopaedic care, Prashanth
Hospitals—one of Chennai’s leading multi-specialty healthcare providers—has become the first in the
city to complete over 500 robotic knee replacement surgeries using the state-of-the-art 4 th
Generation Velys Robotic-Assisted System. This milestone comes at a critical time, as India faces an
arthritis epidemic, with over 100 million people affected by the condition. Leading this achievement is
Dr. Arumugam S, Senior Orthopaedic Surgeon and Joint Replacement Expert at Prashanth Hospitals,
who now ranks among the top five surgeons in India to cross the 500-surgery mark using the 4th Gen
Velys system.
Osteoarthritis, especially in the knees, has seen a sharp rise among people over 60 due to sedentary
lifestyles, obesity, and aging. According to the Indian Journal of Orthopaedics, knee arthritis in India is
15 times more prevalent than in Western nations — making precision-driven treatment essential. This
milestone by Prashanth Hospitals sets a new benchmark by enabling anatomically aligned, rotational
knee movements that closely mimic natural function—leading to shorter hospital stays, quicker
recovery, and patients walking within a day and regaining near-normal mobility in just a month.
Commenting on the occasion, Dr. Arumugam S, Senior Orthopaedic Surgeon and Joint Replacement
Expert at Prashanth Hospitals, said: “India is slowly becoming the arthritis capital of the world—much
like it is with diabetes. We’re now seeing younger patients, even in their early 50s, requiring knee
replacements. Watching them walk out pain-free within days is a powerful reminder of why this
advancement matters. Robotic technology has moved beyond the one-size-fits-all approach. It has
enabled me to do patient-specific alignment—something conventional techniques simply can’t
offer—resulting in more precise, personalized, and effective knee replacements. As someone who also
mentors surgeons across India and Southeast Asia in robotic joint replacement, it’s incredibly
rewarding to see how technology is transforming care at every level.”

Once affecting just 1 in 10 senior citizens, arthritis now impacts 3 to 4 out of every 10 Indians over the
age of 60—with severe cases increasingly seen in patients as young as their early 40s and 50s. This
surge is driven by sedentary lifestyles, obesity, lack of exercise, and prolonged hours of desk-bound
work. Women, notably, account for over 75% of the knee replacement cases at Prashanth Hospitals, a
trend consistent across the country. Reflecting the broader momentum, the adoption of robotic
systems is expanding rapidly—even in Tier 2 and Tier 3, marking a significant step toward more
accessible, precise, and patient-specific orthopaedic care.

Dr. Prashanth Krishna, Managing Director of Prashanth Hospitals, shared the broader vision behind
this technological advancement: “Being the city’s first to use the latest 4th Gen Velys Robot and
successfully complete over 500 robotic knee replacement surgeries marks a major milestone in our
commitment to advanced healthcare at Prashanth Hospitals. This is not just about numbers—it’s about
helping patients regain mobility and confidence through precision-driven care. Robotic-assisted surgery
enables us to replicate natural knee movement with exceptional accuracy, resulting in faster recovery
and better long-term outcomes. As robotic adoption grows across India, Prashanth Hospitals remains
one of the pioneers in integrating both Velys for orthopaedics and SSI Mantra for soft tissue surgeries,
making us one of the few centres in Tamil Nadu to offer multi-specialty robotic capabilities under one
roof. Our goal has always been to bring world-class innovation to Chennai, and this achievement
reflects our dedication to transforming lives through cutting-edge care.”
About Prashanth Hospitals: Prashanth Hospitals is a multidisciplinary hospital that provides sophisticated and
dedicated healthcare services by professionally trained experts. Prashanth Super-specialty Hospital at Velachery
and Kolathur is one of the best- and well-known multi- specialty hospitals in Chennai. These facilities have well
trained and skilled nursing staff who can take good care of the patients. The vision is to become an
internationally renowned medical institute by providing excellent health care services to the patients, and the
mission is to maintain the trust of the patient by providing good quality of health care. The values on which
Prashanth Super-specialty Hospitals function are quality of care, respect, competence, the effectiveness of the
treatment, safety, and creating health awareness among the people. Prashanth Super- specialty Hospitals also
provides various health care packages for check-ups and diagnosis of any ailment and their treatments.

CTS Speciality Hospital Brings Robotic Knee Surgery Ushering in a New Era of Joint Care

deccanwebtv Jun 23, 2025

Chennai, June 22, 2025: CTS Speciality Hospital, a trusted name in orthopedic care in Chennai, has introduced robot-assisted total knee replacement procedures at its Anna Nagar facility, becoming the only hospital in the area to offer this cutting-edge technology known for ensuring surgical precision, minimising risks, and promoting quicker, safer recovery.

The robotic system, developed by the US-based VELYS a leader in orthopedic robotics was officially launched by Mr. M. K. Mohan, MLA of Anna Nagar , in the presence of Dr. Prakash Selvam, Chairman, and Dr. Radhika Venugopal, Managing Director of CTS Speciality Hospital.

CTS Speciality Hospital is a 35-bed facility dedicated to advanced orthopedic care, led by Dr. Prakash Selvam, a seasoned orthopedic surgeon with over 20 years of clinical and surgical experience. Reputed for joint replacement and complex orthopedic procedures, the hospital has a multidisciplinary team of experts in joint replacement, arthroscopy, trauma care, sports injuries, and rehabilitation.

In his comments on the launch of robot-assisted procedure, Dr. Prakash Selvam said, “We are proud to introduce the future of orthopedic care to the people in this region with the launch of the VELYS robotic-assisted solution. While traditional knee replacement surgeries are effective, they often rely heavily on the surgeon’s skill and can vary in outcome. Robot-assisted technology enhances precision by using advanced mapping and real-time data to tailor each procedure to the patient’s unique knee anatomy. This results in more accurate implant placement, reduced tissue damage, minimal blood loss, and faster recovery. Patients benefit from improved joint alignment, greater stability, reduced pain, and better long-term mobility with a shorter hospital stay. Our strengths lie not only in surgical precision, but also in thorough pre-operative planning, personalised recovery programs, and long-term joint health management.”

CTS will not be limiting the robot-assisted surgery only to knee replacements—it will apply the technology to other orthopedic procedures, particularly hip replacements and partial joint reconstructions. “The enhanced precision of robotic systems allows for optimal implant positioning and alignment, which is critical not only in total knee arthroplasty but also in complex hip surgeries, including total hip replacements and revisions. Looking ahead, we are planning to expand robotic applications to include procedures such as unicompartmental (partial) knee replacements, shoulder arthroplasty, and even spine surgeries, based on patient suitability and future technological advancements,” he added.

On the significance of the surgeon’s expertise in robot-assisted surgery, Dr. Prakash Selvam said, “While robot-assisted technology enhances precision and consistency in knee surgeries, human expertise remains absolutely essential for successful outcomes. Robots are valuable tools—they assist with preoperative planning, ensure accurate bone cuts, and help align implants with sub-millimeter accuracy. However, it is the surgeon who makes critical decisions in real time, guided by the patient’s anatomy, joint condition, and overall health. Every patient presents unique challenges that demand clinical judgment, adaptability, and experience—qualities no machine can replicate. From selecting the appropriate implant to managing unexpected intraoperative findings, it is the surgeon’s skill that ensures the technology delivers its full potential.”

Paterson Cancer Center organized Free Cancer Detection Camps from 19th to 22nd for General Public

deccanwebtv Jun 20, 2025

Chennai, 19th June 2025: Paterson Cancer Center Pvt Ltd has completed its 22nd years and entered into 23rd anniversary. It has been started with the purpose of Cancer Free Society In India, as envisaged by none other than the 11th President of India, Dr APJ Abdul Kalam who was the Chairman of Paterson Cancer Center, prior to becoming the President of India.

Paterson Cancer Center maintains its purpose of conducting awareness camps both for children and general public, Free Cancer Detection Camps and Continuing Medical Education for general physician and specialist.

In this year, the camp has started on Thursday the 19th of June 2025 and extended up to Sunday the 22nd of June 2025. The inaugural function was attended by more than 100 people.

Shri N Arunachalam, the retired District Judge was presiding over the function. During his speech, he insisted upon the role of early detection, as his mother died of Metastatic Adeno Carcinoma Of Liver – Primary Colon and about which no one was aware of (40 years ago) requested all the press and media people, you tubers to spread the message and convince the public to participate more in such camps. As a Judge he felt that even his 60th birthday should be celebrated only by conducting such camps in his village rather than giving parties and gathering crowd

Dr B Kumaravel MD., Managing Director of Vijay’s Nursing Home, has nicely explained that the simple tumor markers can give a clue of the possibility of the erupting cancers even though the persons may be looking normal.

Dr S Krishnan MD., Managing Director of Srinivasan Rajalakshmi Memorial Hospital, has requested in his address that the Deputy Mayor should conduct similar awareness camps within The Greater Corporation Of Chennai

Dr Soundarajan Nephrologist was also requesting the Deputy Mayor to start compulsory cancer detection camps for all the corporation workers, employees in the respected Corporation hospitals.

Shri Eldred Kumar, film producer was thrilled about the whole event and thanking Paterson Cancer Center team for conducting public camps at Thangachimadam where he was born. He was relating his Association with Dr APJ Abdul Kalam when he was young.

The Deputy Mayor – Shri Mahesh Kumar spoke well about the importance of such camps and narrated the role of Corporation in bringing health awareness and sanitation of the public places to prevent epidemic and endemic diseases for which he as a mayor is part of.

Dr Aadarsh Raghavan MS., M.Ch., Surgeon, Dr Usha Vijayaraghavan MD., Anaesthesiologist and Director of Paterson Cancer Center, Dr S Vijaya Raghavan MD. Clinical Oncologist and Managing Director, Paterson Cancer Centre welcomed all the participants attending the camp

Shri PT Govindarajan, Trustee, CALF (Cancer Alleviation Foundation) served the vote of thanks and the ceremony ended with National Anthem.

மார்பக புற்றுநோய் குறித்த விழிப்புணர்வை ஊக்குவிக்கும் அப்போலோ மருத்துவமனை…

deccanwebtv Jun 12, 2025

மார்பக புற்றுநோய் குறித்த விழிப்புணர்வை ஊக்குவிக்கும் அப்போலோ மருத்துவமனையின் CSR பிரச்சாரத்திற்கு திருமதி. உபாசனா காமினேனி கொனிடேலா ஆதரவு

அப்போலோ மருத்துவமனையின் CSR பிரிவின் துணைத் தலைவரான திருமதி உபாசனா காமினேனி கொனிடேலா மார்பக புற்று நோய் குறித்தான விழிப்புணர்வை ஊக்குவிக்கும் CSR பிரச்சாரத்திற்கு தனது ஆதரவை வழங்கி உள்ளார்.

நாடு முழுவதும் 23 நகரங்களில் இந்தப் பிரச்சாரம் நடத்தப்படும். இதில் அப்போலோ டெலி மெடிசின் நெட்வொர்க்கிங் அறக்கட்டளை நடைமுறைப்படுத்தும் நிறுவனமாக செயல்படுகிறது.

மார்பக புற்றுநோய் குறித்த விழிப்புணர்வை ஏற்படுத்துவதும், பெண்கள் தங்கள் ஆரோக்கியத்தை பொறுப்பேற்க ஊக்குவிப்பதும் தான் இந்த CSR பிரச்சாரத்தின் நோக்கமாகும்.

ஹைதராபாத், ஜூன் 11, 2025: சுகாதார துறை சார்ந்த தொழில்நுட்பத்தில் முன்னணியில் உள்ள FUJIFILM இந்தியா, அப்போலோ மருத்துவமனை அறக்கட்டளையின் CSR பிரிவின் துணைத் தலைவர் திருமதி உபாசனா காமினேனி கொனிடேலா முன்னிலையில் , ”முன்னரே கண்டறிதல், முன்னரே போராடுதல்” ( Find It Early, Fight It Early) எனும் அதன் சமீபத்திய CSR பிரச்சாரத்தை தொடங்கியுள்ளது. இந்த முயற்சி மார்பக புற்றுநோய் மற்றும் அதன் ஆரம்ப கால நோய் பாதிப்பினைக்கண்டறிதலின் முக்கியத்துவம் குறித்த விழிப்புணர்வை ஏற்படுத்துவதில் கவனம் செலுத்துகிறது. குறிப்பாக பெண்களின் ஆரோக்கியம் குறித்த விவாதங்கள் பெரும்பாலும் நடைபெறாத அல்லது எதிர்மறையான- நியாயமற்ற நம்பிக்கைகளை கொண்டிருக்கும் பகுதிகளில் விழிப்புணர்வை ஏற்படுத்துவதில் கவனம் செலுத்துகிறது.

இந்த விழிப்புணர்வு பிரச்சாரம் இந்தியா முழுவதும் 23 நகரங்களில் செயல்படுத்தப்படும். கட்டமைக்கப்பட்ட சமூக ஈடுபாடு – சுகாதார இடர் மதிப்பீடுகள் மற்றும் உணர்திறன் முயற்சிகள் மூலம் ஒரு லட்சத்திற்கும் மேற்பட்ட பெண்களை சென்றடைவதை நோக்கமாக கொண்டுள்ளது. மேலும் இந்த பிரச்சாரம், இதற்காக பிரத்யேகமாக பயிற்சி பெற்ற களக் கல்வியாளர்களால் வழிநடத்தப்படும். அப்போலோ டெலி மெடிசின் நெட்வொர்க்கிங் அறக்கட்டளை ( ATNF) செயல்படுத்தும் இந்த திட்டம், அதிக அளவில் தகவல்களை அறிந்த மற்றும் சுகாதார விழிப்புணர்வு உள்ள சமூகத்தை உருவாக்குவதற்கான FUJIFILM இந்தியாவின் உறுதிப்பாட்டை பிரதிபலிக்கிறது.

மார்பக புற்றுநோய் இந்திய பெண்களிடையே மிகவும் பரவலாக காணப்படும் புற்று நோய்களில் ஒன்றாகும். ICMR எனப்படும் இந்திய மருத்துவ ஆராய்ச்சி கவுன்சிலின் தேசிய புற்றுநோய் பதிவு திட்டத்தின் படி, பெண்களிடையே கண்டறியப்பட்ட அனைத்து வகையான புற்று நோய்களிலும் இது தோராயமாக 14 சதவீதம் ஆகும். மேலும் 29 பெண்களில் ஒருவருக்கு இந்த நோய் உருவாகும் அபாயமும் உள்ளது. துரதிஷ்டவசமாக இது பற்றிய அறியாமை , விழிப்புணர்வு இன்மை, சரியான நேரத்தில் நோயை கண்டறிவதற்கான வசதிகள் எளிதில் கிடைக்காதது மற்றும் பராமரிப்பு கிடைக்காததால்.. பெரும்பாலான வழக்குகள்.. நோய் முற்றிய நிலையிலேயே கண்டறியப்படுகின்றன.‌ ‘முன்னரே கண்டறிதல், முன்னரே போராடுதல்” என்பது சமூகத்தில் நம்பகமான, கலாச்சார ரீதியாக உணர்திறன் வாய்ந்த தகவல்களை வழங்குவதன் மூலம், இந்த சவால்களை எளிதாக எதிர்கொள்ளும் வகையில் வடிவமைக்கப்பட்டுள்ளது. இது தொடர்பான ஆரோக்கியமான விவாதங்கள் – விழிப்புணர்வை ஏற்படுத்தும் அமர்வுகள் மூலமும் மரியாதையுடன் கூடிய திறந்த நிலையிலான உரையாடல்களை நிகழ்த்தி எளிதாக்குவதன் மூலம் .. இந்த முயற்சி பெண்கள் தங்களின் உடல் நலம் குறித்து மிகவும் விழிப்புணர்வுடனும் முன் முயற்சியுடனும் செயல்பட ஊக்குவிக்கிறது. ஆரம்பக் கட்ட அறிகுறிகளை அறிந்து கொள்வது மற்றும் கண்டறிவது, சுய பரிசோதனைக்கான நுட்பங்களை புரிந்து கொள்வது மற்றும் சரியான தருணத்தில் முழுமையான மருத்துவ ஆலோசனையை பெறுவது உள்ளிட்டவைகளும் இதில் அடங்கும்.‌

இது தொடர்பாக அப்போலோ மருத்துவமனையின் CSR பிரிவின் துணைத் தலைவரான திருமதி. உபாசனா காமினேனி கொனிடேலா பேசுகையில், ”சுகாதாரத் துறையில் முன்னணியில் இருக்கும் நாங்கள் நோய்க்கு சிகிச்சை அளிப்பதுடன் மட்டுமல்லாமல், அது குறித்த விழிப்புணர்வு , கல்வி, எளிதில் அணுகும் முறை ஆகியவற்றை வழங்கும் பொறுப்பும் எங்களுக்கு உள்ளது. மார்பக புற்றுநோய் தொடர்ந்து உயிர்களை கொன்று வருகிறது. ஏனெனில் பல பெண்களுக்கு இத்தகைய நோய் பாதிப்பை கண்டறிந்து முன்கூட்டியே செயல்படுவதற்கு தேவையான தகவல்களும், வசதிகளும் இல்லை. FUJIFILM இந்தியாவின் இந்த CSR முயற்சி அந்த யதார்த்தத்தை பற்றிய ஆழமான புரிதலை பிரதிபலிக்கிறது. மிகவும் முக்கியமான இடங்களில் அர்த்தமுள்ள நடவடிக்கை மேற்கொள்வதற்கும் , தாமதமாகிவிடும் முன் விழிப்புணர்வு தேவைப்படும் பெண்களை சென்றடைவதை உறுதி செய்வதற்கும் பகிர்ந்துக் கொள்ளப்பட்ட உறுதிப்பாட்டில் எங்களது ஆதரவு அடித்தளமாக உள்ளது என்றார்.

இது தொடர்பாக FUJIFILM இந்தியாவின் நிர்வாக இயக்குநரான திரு கோஜி வாடா தொடர்ந்து பேசுகையில், ” எங்களின் FUJIFILM இந்தியா, ‘ நம் உலகிற்கு மேலும் அதிகளவிலான புன்னகைகளை வழங்குதல்’ ( Giving Our World More Smiles) என்ற எங்கள் குழுவின் நோக்கத்தை உள்ளடக்கிய புதுமையான தயாரிப்புகள் மற்றும் தீர்வுகளை வழங்க நாங்கள் உறுதிபூண்டுள்ளோம்.‌ பல்வேறு ஆலோசனைகள், தனித்துவமான திறன்கள் மற்றும் அசாதாரணமான மக்களுடன் கலந்து கொள்வதன் மூலம் உலகிற்கு மகிழ்ச்சியையும் , புன்னகையும் தரும் தீர்வுகளை உருவாக்குவதை நோக்கமாக கொண்டுள்ளோம். ‘முன்னரே கண்டறிதல், முன்னரே போராடுதல் ‘ எனும் மார்பக புற்றுநோய் குறித்த விழிப்புணர்வு CSR பிரச்சாரத்தின் மூலம் மார்பக புற்றுநோய் குறித்த விழிப்புணர்வை விரிவுபடுத்துவதையும், இதனால் இறக்கும் பல உயிர்களை காக்கும் வகையில் ஆரம்ப கால நோயறிதலை மேம்படுத்துவதையும் நாங்கள் நோக்கமாக கொண்டுள்ளோம்” என்றார்.

FUJIFILM இந்தியா தனது CSR முயற்சிகள் மூலம் பூர்த்தி செய்யப்படாத மருத்துவ தேவைகளை நிவர்த்தி செய்வதன் மூலமும், ஆரம்பகால நோய் கண்டறிதலை ஊக்குவிப்பதன் மூலமும், கல்வி மூலமும், தடுப்பு மற்றும் பராமரிப்பை செயல்படுத்துவதன் மூலமும், சுகாதார பராமரிப்பை கூடுதலாக உள்ளடக்கியதாகவும் , எளிதில் அணுகக் கூடியதாகவும் மாற்றுகிறது. ‘முன்னரே கண்டறிதல், முன்னரே போராடுதல்’ என்ற FUJIFILM குழுமத்தின் நிலையான மதிப்பு 2030 ஆம் ஆண்டிற்கான திட்டத்துடன் ஒத்துப் போகிறது. இது குறைவான பிரதிநிதித்துவம் பெற்ற மக்களுக்கு சுகாதார சமத்துவம் மற்றும் ஆதரவிற்கு முன்னுரிமை அளிக்கிறது. இந்த முயற்சி தேவைப்படும் இடங்களில் தாக்கத்தை ஏற்படுத்துவதன் மூலம் ‘நம் உலகிற்கு அதிக புன்னகையை வழங்குதல்’ என்ற எங்கள் நிறுவனத்தின் நோக்கத்தை பிரதிபலிக்கிறது. தொலைதூரம் உள்ள நகரமாக இருந்தாலும் அல்லது அடர்த்தியான நகர் புறமாக இருந்தாலும் ஒவ்வொரு பெண்ணும் தனது ஆரோக்கியத்தை பற்றி முழுமையாக அறிந்து கொள்ளவும், அதனை பாதுகாத்துக் கொள்ளவும், தனது ஒட்டு மொத்த நல்வாழ்விற்கான பொறுப்பினை ஏற்கவும், அதற்கான வாய்ப்பினை பெற தகுதியானவர் என FUJIFILM இந்தியா நம்புகிறது.

MGM Healthcare Unveils ‘Nalam’ Clinic for Personalised Medical Weight Loss Solutions

deccanwebtv Jun 1, 2025

Chennai, 31 May 2025: MGM Healthcare has launched the ‘Nalam’ Institute for Metabolic Disorders and Hormonal Health to provide personalised, result-oriented weight loss support through medical care, nutrition guidance, lifestyle interventions, psychological counselling, and surgical options. Backed by a multidisciplinary team, the clinic will adopt a scientific and holistic approach—leveraging advances in medical science to assess individuals’ metabolic and hormonal profiles, as well as continual support, essential for producing results.

Actor Ms. Khushbu Sundar inaugurated the institute in the presence of senior management and key members of the hospital’s medical team.

Among Nalam’s flagship treatment plans is a personalised 3-month weight management program designed to shed excess fat, and to improve blood sugar levels, and cholesterol. Guided by specialists, the program ensures both safety and effectiveness. It also promotes lasting lifestyle changes, helping individuals achieve their long-term health goals.

In their comments, Dr. Urjitha Rajagopalan, Director, MGM Healthcare, said, “Overweight and obesity have emerged as one of the most pressing public health concerns of our time. One in 8 people worldwide are now living with obesity. In India, 24% of women, 23% of men, and about 8% of children are classified as overweight or obese. To combat this public health concern, we need personalised weight management guided by metabolic assessments and personalised insights into dietary science. Our newly launched ‘Nalam’ is a step forward in that direction. It brings together a multidisciplinary team—doctors, dietitians, psychologists, physiotherapists, and surgeons—to deliver a holistic, personalised care plan. More importantly, our commitment is not just to provide medical advice, but to walk with each individual on their journey until they achieve sustainable results and embrace healthier lifestyles.”

In his comments, Dr. M. Swamikannu, Director & Senior Consultant, Internal Medicine, said, “Obesity is not just a matter of appearance or weight—it significantly increases the risk of serious non-communicable diseases (NCDs) such as cardiovascular and cerebrovascular diseases, hypertension, type 2 diabetes, and even certain cancers. We are pleased to introduce a specialised, science-based and result-oriented approach for people to lose weight. Our program follows a streamlined process, beginning and a multidisciplinary team is involved from the start. Patients undergo consultations with an endocrinologist for detailed metabolic evaluation and tailored medication, followed by sessions with dietitians who address eating habits, and nutritional needs. Based on these insights, we create customised diet and lifestyle plans. Psychologists also play a key role in the individual’s weight management journey.”

Apollo Cancer Centres Introduces #OraLife– the Screening Programfor Early Detection of Oral Cancer

deccanwebtv May 30, 2025

Chennai, May 30, 2025: Tobacco use is no longer a personal habit—it’s a national health crisis. India accounts for nearly one-third of global oral cancer cases, with 77,000 new diagnoses and 52,000 deaths annually. The survival rate stands at just 50%, significantly lower than in developed countries (link). This alarming trend is compounded by rising tobacco consumption across both urban and rural India, as highlighted by the Household Consumption Expenditure Survey (2022–23) (Link), which noted increased spending on paan, tobacco, and other intoxicants.
On account of World No Tobacco Day, Apollo Cancer Centres (ACC) has launched #OraLife, a proactive screening initiative focused on the early detection of oral cancer. The program emphasizes public awareness, routine screening, and targeted intervention particularly for high-risk individuals, including tobacco users, alcohol consumers, those with HPV-16 infection, and people with prior oral lesions.
Adding strength to this initiative, ACC has partnered with the Isha Foundation to provide holistic support for individuals seeking to overcome tobacco addiction. This collaboration integrates physical health interventions with mental and emotional wellness support.
Doctors those who took part in the panel emphasized that tobacco users are 6 to 7 times more likely to develop oral cancer that non-users. Since oral cancer can often be detected early though a simple oral examination, the #OraLife initiative encourages everyone over 30 years of age, especially tobacco users to undergo regular screenings. Early detection significantly improves treatment outcomes and survival rates. Healthcare professionals urge the public to adopt preventive healthcare practices and take advantage of the screening program. “By fostering the culture of prevention, we can reduce the impact of oral cancer and enhance the overall health,” said the clinicians in unison.

Oral cancer is the most common cancer among Indian men and is rising steadily among women. Incidence rates vary widely across states: West Bengal reports the highest, while Kerala sees the lowest. Maharashtra, Ahmedabad Urban, and Meghalaya also report alarmingly high figures—largely driven by tobacco use. Chennai-based studies have identified an increase in cancers of the tongue base and floor of the mouth, sites known for high metastatic potential. The buccal mucosa remains the most frequently affected site nationwide. Notably, smokeless tobacco use is rising among women, contributing to a narrowing gender gap in incidence rates.(Link)

Risk factors—such as the combined use of smokeless tobacco, betel quid, and alcohol—are especially prevalent in underserved communities with limited access to preventive care. The disease is increasingly affecting individuals aged 31–50, with poor nutrition further exacerbating the risk.
The #OraLife, the Oral Cancer Screening Program, involves a comprehensive visual and tactile oral examination conducted by trained medical oncologists and head & neck surgeons. It aims to identify early warning signs such as persistent ulcers, red or white patches, lumps, and non-healing sores—many of which are often overlooked.

To support mental and emotional recovery, Apollo has teamed up with the Isha Foundation to incorporate spiritual well-being into its tobacco cessation efforts. As part of this, individuals will have access to a simple yet effective 7-minute guided meditation led by Sadhguru.
“Miracle of Mind” is a free meditation app that empowers individuals to take charge of their well-being. With over 2 million downloads, the app features guided meditations, streak tracking, personalized messages, and motivational rewards,” said a spokesperson from the Isha Foundation.
“This initiative represents Apollo’s leadership in holistic oncology care “Our mission goes beyond treatment—we aim to equip individuals with the tools and knowledge to take control of their health. Our collaboration with Isha Foundation is a testament to our belief in integrated care, where early detection and mental wellness are both critical pillars.” Said Mr. Karan Puri, Chief Executive Officer, Apollo Cancer Centre (ACC) and Apollo Proton cancer Centre(APCC).
In addition to the health burden, the initiative also addresses the financial and emotional toll of tobacco use. Research indicates that tobacco users spend over ₹1.1 lakh more on healthcare over their lifetime compared to non-users. The consequences extend beyond health—tobacco use reduces life expectancy, raises insurance premiums, limits claim payouts, and destabilizes families, particularly when primary earners are affected.
Through the #CutTheCost campaign, Apollo Cancer Centres calls on tobacco users to re-evaluate the true cost of their habits—not just in terms of health, but also financial security and emotional well-being. The campaign reinforces the value of early detection and long-term lifestyle change as the most powerful tools for prevention.